fda approves first oral glp-1 obesity drug august 21 2025 Zealthy | The pill everyone's been asking about just got approved. Swipe to see how it compares to the injection. 💊➡️ #weightloss #glp1 Found introducing oral dissolvable GLP-1

Ipamorelin is a Growth Hormone Releasing Peptide (GHRP), pentapeptide ( 5 amino acids), and ghrelin agonist

"The adipose tissue (AT) expandability hypothesis explains that the individual capacity to appropriately store energy surplus as fat within the AT prevents the toxic deposition of lipids in other organs, such as the pancreas. Looping back to the role of the brain in obesity, I would move one level higher in the cascade of downstream effects - to the central regulation of hedonic appetite and the wiring of the reward system, overexpressed obesogenic genes within the CNS, and the role of ultra-processed food

Journal of Chromatography A, 1139(1), 130135

Phillip Frost Department of Dermatology and Cutaneous Surgery in Miami, Florida, and the Department of Dermatology at George Washington University School of Medicine and Health Sciences in Washington, District of Columbia